Genmark Diagnostics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Genmark Diagnostics generated cash of $6,134,000, which is more than the previous year. Cash used in financing activities reached the amount of $87,570,000 last year. Net change in cash is therefore -$2,900,000.
Cash Flow
| 2011 | -19.21M | -7.11M | 33.26M |
|---|---|---|---|
| 2012 | -16.24M | -2.14M | 44.31M |
| 2013 | -23.79M | -72.56M | 80.83M |
| 2014 | -29.57M | 29.41M | 1.28M |
| 2015 | -31.91M | 19.32M | 11.13M |
| 2016 | -35.63M | -24.12M | 40.35M |
| 2017 | -53.42M | -24.90M | 89.05M |
| 2018 | -32.51M | 33.94M | 8.06M |
| 2019 | -34.92M | -2.17M | 45.17M |
| 2020 | 6.13M | -96.50M | 87.57M |
GNMK Cash Flow Statement (2011 – 2020)
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 45.11M | 37.04M | 27.51M | 15.95M | 35.38M | 36.85M | 35.72M | 51.25M | 25.32M | 18.32M |
Operating activities | ||||||||||
Net income | -18.64M | -47.35M | -50.5M | -61.85M | -50.60M | -42.19M | -38.26M | -33.64M | -22.10M | -23.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 7.06M | 7.26M | 7.08M | 5.31M | 3.91M | 3.40M | 2.65M | 2.53M | 1.19M | 1.32M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.89M | 2.35M | 1.87M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.89M | 2.35M | 1.87M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -4.10M | -5.58M | -878K | -1.55M | -2.25M | -1.98M | -2.03M | -2.39M | -2.06M | -420K |
Inventories | -12.47M | -6.53M | -2.41M | -10.51M | -3.45M | -1.28M | -229K | -1.31M | 880K | -1.74M |
Accounts payable | 5.22M | 1.50M | -1.38M | 2.55M | 4.10M | -757K | 85K | 1.34M | 728K | 378K |
Cash generated by operating activities | 6.13M | -34.92M | -32.51M | -53.42M | -35.63M | -31.91M | -29.57M | -23.79M | -16.24M | -19.21M |
Investing activities | ||||||||||
Purchases Of Investments | -114.18M | -32.13M | -29.77M | -70.98M | -33.68M | -22.64M | -28.05M | -76.19M | 0 | -5M |
Investments In Property Plant And Equipment | -17.77M | -2.09M | -2.57M | -5.31M | -8.5M | -4.30M | -6.07M | -5.15M | -3.47M | -1.37M |
Acquisitions Net | 0 | 0 | 0 | 500K | 1.5M | 550K | 350K | 882K | 0 | 0 |
Cash generated by investing activities | -96.50M | -2.17M | 33.94M | -24.90M | -24.12M | 19.32M | 29.41M | -72.56M | -2.14M | -7.11M |
Financing activities | ||||||||||
Common Stock Issued | 78.65M | 14.02M | 1.06M | 87.26M | 30.92M | 884K | 812K | 86.54M | 48.3M | 34.53M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -5.46M | 0 | 0 | 0 | -5.51M | 0 | -2.85M |
Repayments of term debt | -57K | 0 | -92K | 0 | -40K | 0 | -56K | -766K | -1.98M | -417K |
Cash used in financing activities | 87.57M | 45.17M | 8.06M | 89.05M | 40.35M | 11.13M | 1.28M | 80.83M | 44.31M | 33.26M |
Net Change In Cash | -2.9M | 8.07M | 9.53M | 10.79M | -19.42M | -1.47M | 1.13M | -15.52M | 25.93M | 6.99M |
Cash at end of period | 42.21M | 45.11M | 37.04M | 26.75M | 15.95M | 35.38M | 36.85M | 35.72M | 51.25M | 25.32M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |